Geode Capital Management, LLC Aquestive Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,667,515 shares of AQST stock, worth $7.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,667,515

Previous 1,576,972 5.74%

Holding current value

$7.85 Million

Previous $4.1 Million 102.54%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.4 - $5.09 $217,303 - $460,863	90,543 Added 5.74%	1,667,515 $8.3 Million
Q2 2024 Aug 09, 2024	BUY	$2.31 - $4.5 $2.4 Million - $4.67 Million	1,038,516 Added 192.87%	1,576,972 $4.1 Million
Q1 2024 May 13, 2024	BUY	$2.01 - $6.09 $87,543 - $265,243	43,554 Added 8.8%	538,456 $2.29 Million
Q4 2023 Feb 13, 2024	BUY	$1.29 - $2.47 $49,454 - $94,692	38,337 Added 8.4%	494,902 $999,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.24 $68,382 - $102,117	45,588 Added 11.09%	456,565 $698,000
Q2 2023 Aug 11, 2023	BUY	$1.06 - $2.49 $24,806 - $58,270	23,402 Added 6.04%	410,977 $678,000
Q4 2022 Feb 13, 2023	BUY	$0.77 - $1.18 $16,690 - $25,577	21,676 Added 5.92%	387,575 $349,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $1.73 $76,568 - $210,259	121,537 Added 49.74%	365,899 $428,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.57 $6,486 - $26,046	-10,135 Reduced 3.98%	244,362 $156,000
Q1 2022 May 13, 2022	BUY	$2.28 - $4.26 $458 - $856	201 Added 0.08%	254,497 $664,000
Q4 2021 Feb 11, 2022	BUY	$3.69 - $6.37 $127,880 - $220,758	34,656 Added 15.78%	254,296 $989,000
Q3 2021 Nov 12, 2021	SELL	$3.25 - $4.66 $6 - $9	-2 Reduced -0.0%	219,640 $957,000
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $444,854 - $704,464	-135,214 Reduced 38.1%	219,642 $871,000
Q1 2021 May 12, 2021	BUY	$4.17 - $6.73 $173,188 - $279,510	41,532 Added 13.26%	354,856 $1.85 Million
Q4 2020 Feb 12, 2021	BUY	$4.65 - $7.79 $176,262 - $295,287	37,906 Added 13.76%	313,324 $1.68 Million
Q3 2020 Nov 13, 2020	BUY	$4.12 - $9.09 $20,484 - $45,195	4,972 Added 1.84%	275,418 $1.34 Million
Q2 2020 Aug 13, 2020	BUY	$1.84 - $6.44 $223,296 - $781,539	121,357 Added 81.4%	270,446 $1.31 Million
Q1 2020 May 14, 2020	BUY	$1.54 - $6.75 $93,972 - $411,891	61,021 Added 69.29%	149,089 $326,000
Q4 2019 Feb 13, 2020	BUY	$3.06 - $8.78 $172,051 - $493,664	56,226 Added 176.58%	88,068 $512,000
Q3 2019 Nov 12, 2019	SELL	$3.04 - $4.91 $4,131 - $6,672	-1,359 Reduced 4.09%	31,842 $101,000
Q2 2019 Aug 14, 2019	SELL	$3.72 - $6.95 $156,731 - $292,817	-42,132 Reduced 55.93%	33,201 $139,000
Q1 2019 May 14, 2019	BUY	$5.74 - $8.05 $178,657 - $250,556	31,125 Added 70.41%	75,333 $520,000
Q4 2018 Feb 13, 2019	BUY	$6.09 - $18.0 $117,597 - $347,580	19,310 Added 77.56%	44,208 $278,000
Q3 2018 Nov 13, 2018	BUY	$15.0 - $18.96 $373,470 - $472,066	24,898 New	24,898 $435,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

46.8M

Call Options Held

517K

Put Options Held

207K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $251M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Aquestive Therapeutics, Inc. Transaction History